Skip to main content

Table 3 Percent difference of the simplified methods for absorbed dose calculations and the effective half-lives

From: Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

  Left kidney Right kidney
Percent difference in Absorbed dose AD147 vs AD14 − 2.5 (− 20.1–71.8) − 2.6 (− 39.6–52.4)
AD147 vs AD17 2.9 (− 21.6–29.6) 2.8 (− 17.7–31.4)
AD147 vs AD4/52 − 6.4 (− 51.0–27.4) − 6.0 (− 59.2–27.3)
AD147 vs AD4/H − 3.3 (− 45.5–31.2) − 3.1 (− 57.9–29.8)
AD14 vs AD4/52 − 2.9 (− 67.5–4.5) − 2.6 (− 63.3–4.8)
AD14 vs AD4/H 0.0 (− 62.3–6.1) 0.4 (− 58.3–6.0)
Percent difference in effective half-lives teff,147 vs teff,14 − 8.8 (− 79.1–89.4) − 8.6 (− 87.6–66.0)
teff,147 vs teff,17 0.0 (− 8.5–4.0) 0.0 (− 8.5–4.3)
  1. Data are presented as median (range)